Coverage
-
April 13, 2022
An Oklahoma federal judge won't let EISAI Inc. and Arena Pharmaceuticals Inc. trim most claims from a suit alleging the weight loss drug Belviq caused a woman to develop breast cancer, saying the complaint sufficiently alleges they were aware of the drug's risks but pushed it to market anyway.
1 other articles on this case.
View all »